Login
Blog
Instagram
Facebook
Twitter
LinkedIn
Youtube
Inquiries
Kakao Talk
QWhat inspired you to create and domesticate Korea's first dental implant?
In the 1990s, the dental implant market was dominated by foreign products, often priced exorbitantly high, making treatments financially burdensome for patients. I envisioned a future where Korean patients could access superior implants at more reasonable prices. Driven by this vision, I left my dental practice and pursued further studies. I invested all my resources into implant technology, developing CAD designs on a 286 computer based on textbook research by esteemed professors. This dedication led to the successful development of Korea's first indigenous implant, Bioplant.
QAfter developing Korea's first domestic implant, you received numerous awards. Which accolade stands out to you the most?
The Fifth Small and Medium Business Technology Innovation Award in 2004 stands out as the most memorable. This honor officially recognized the development of Korea's first dental implant and was personally awarded by the President. This recognition fueled further research, culminating in the development of rhBMP-2 bone graft material. Besides the Bronze Tower Order of Industrial Service Merit, we also received numerous other awards, including the Excellence in Small and Medium Business Award and the Venture Business Award.
QHow was the implant company established?
In 1998, the Asan Medical Foundation became the official manufacturing body for the Bioplant Implant System. In 2000, we rebranded the medical device company to 'CO-WELL' (Cowellmedi) and established it as a corporation. Cowellmedi, founded by passionate customers, has since patented numerous dental implants both domestically and internationally, offering a wide range of products including dental implants, surgical kits, orthodontic tools, and implant accessories.
Our pivotal moment came in 2012 with the launch of the INNO Implant System. In 2010, it became the world's first dental material bone BMP (COWELL BMP) synthesized from E.coli-based rhBMP-2. We host our annual CIC (COWELL International Conference), engaging with dentists worldwide through developments and clinical posters. We also consistently participate in domestic exhibitions such as SIDEX and YEDEX.
QWhat is Cowellmedi’s unique strength?
Cowellmedi’s greatest strength lies in its outstanding product performance. Since developing Korea’s first dental implant, Bioplant Implant, in 1994, and later Axis Implant, the company has accumulated nearly 30 years of clinical experience in implant dentistry. Through the dedication and innovation of our talented researchers, the surface treatment technology applied to INNO implants has showcased Cowellmedi’s excellence in surface technology to the world.
In addition to implants, we also developed the world’s first E. coli–derived rhBMP-2 bone graft material (COWELL BMP) and the non-resorbable membrane Wifi-Mesh. With proven efficacy and stability through continuous research and time, our products are now exported to over 60 countries worldwide.
QWhat is Cowellmedi’s vision for the future?
When I first entered dental school at the age of 20 and later opened my first dental clinic, my heart was filled with excitement and fear, driven by the desire to help others. Even in difficult times, I have strived to uphold my calling — to be someone who helps people.
Moving forward, Cowellmedi’s innovative technologies will continue to bring transformative change to the dental industry, just as they did in 1994, and aim to become a company that benefits many patients around the world. We will keep growing as a global medical device company dedicated to improving human life.
